Inovio Pharmaceuticals (INO) Posts Q1 Results with Data Ahead - Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Inovio Pharmaceuticals, Inc. (INO) Turns Positive
May 12, 2014 2:46 PM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) is moving along with broader markets. Shares are now positive on the session.
Following Q1 results, Inovio dropped as much as 13.4 percent to $1.87. The stock has been crawling back since just after 10am.
Shares are about 0.2 percent higher.
... MoreInovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position
May 12, 2014 6:12 AM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.41 million.
As of March 31, 2014, cash and cash equivalents plus short-term investments were $116.8 million compared with $52.6... More
